Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: Stereotactic Body Radiotherapy for Prostate Cancer [NA]
Clinical trial update reporting completed status for stereotactic body radiotherapy in prostate cancer with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program [NA]
Completed clinical trial evaluating a couple-focused, web-based tailored symptom self-management program to support survivorship care in loc…
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer [Phase 2]
Phase 2 trial evaluating olaparib before surgery in localized prostate cancer; study terminated with posted results in 2020.
-
FDA approval · 2020-09-17FDA Approved: YONSA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for YONSA (abiraterone acetate) submitted by Sun Pharmaceutical Industries, Inc., updating the l…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Survivorship Promotion In Reducing IGF-1 Trial [Phase 2]
Phase 2 trial evaluating survivorship promotion by reducing IGF-1 has completed, with results posted in 2020.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer [Phase 2]
Phase 2 trial update evaluating enzalutamide in combination with PSA-TRICOM in non-metastatic castration-sensitive prostate cancer has compl…
-
FDA approval · 2020-09-10FDA Approved: DOCETAXEL — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for a generic docetaxel product (docetaxel anhydrous) from Mylan Institutional LLC.
-
FDA approval · 2020-09-04FDA Approved: NILUTAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for nilutamide, confirming regulatory approval for an updated product submiss…
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Neoadjuvant Ipilimumab in Prostate Cancer [Phase 2]
A Phase 2 neoadjuvant trial of ipilimumab in prostate cancer has completed enrollment and posted results as of September 3, 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating carboplatin plus docetaxel in anaplastic prostate cancer.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer [Phase 1, Phase 2]
A pilot Phase 1/2 trial evaluating BR55 ultrasound contrast agent for assessing prostate cancer has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer [Phase 2]
Phase 2 trial assessing sipuleucel-T with or without radiation therapy in hormone-resistant metastatic prostate cancer has completed with re…
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating HDR brachytherapy plus stereotactic ablative radiotherapy for intermediate and high-risk prostate c…
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: 68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating 68Ga-PSMA PET-CT for diagnosis and management of prostate cancer.
-
CLINICAL_TRIALS withdrawal · 2020-08-17Clinical Trial Update: Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer [Phase 3]
Phase 3 trial evaluating apalutamide with radiotherapy and androgen deprivation therapy in prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy [Phase 2]
Phase 2 clinical trial examining erythropoietin to enhance recovery of erectile function after radical prostatectomy.
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial assessing serum testosterone levels in metastatic castration-resistant prostate cancer patients has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Treatment Preference and Patient Centered Prostate Cancer Care [NA]
Clinical trial update regarding treatment preference and patient-centered care for prostate cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating a monoclonal antibody therapy for prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating docetaxel and erlotinib in older patients with prostate cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer [Phase 2]
Phase 2 trial update on stereotactic body radiotherapy (SBRT) for localized prostate cancer.
-
CLINICAL_TRIALS research · 2020-07-27Clinical Trial Update: Ga-68-PSMA-11 in High-risk Prostate Cancer [Phase 1, Phase 2]
Clinical trial update for Ga-68-PSMA-11 in high-risk prostate cancer across phase 1 and phase 2 trials; status completed.
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Multicentre International STudy for the Prevention With Ialuril® of Radio-induced Cystitis (MISTIC) [Phase 2]
Phase 2 multicenter international trial evaluating Ialuril for prevention of radio-induced cystitis in patients with prostate cancer has com…
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201 [Phase 3]
Phase 3 extension study update for SoluMatrix Abiraterone Acetate in patients who completed the primary study for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer [Phase 2]
Phase II randomized trial evaluating three regimens of GX301 vaccination in men with castration-resistant prostate cancer has completed.